Survival and late effects in the risk-stratified hepatoblastoma patients treated by JPLT-2 protocol.

被引：0
|
作者：
Hiyama, Eiso
Kurihara, Sho
Ueda, Yuka
Hishiki, Tomoro
Ida, Kohmei
Iehara, Tomoko
Oue, Takaharu
Yano, Michihiro
Watanabe, Kenichiro
Hoshino, Ken
Ko, Katsuyoshi
Tanaka, Yukichi
机构：
[1] Hiroshima Univ, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Hiroshima, Japan
[3] Japanese Study Grp Pediat Liver Tumor, Hiroshima, Japan
[4] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[5] Japanese Study Grp Pediat Liver Tumor, Osaka, Japan
[6] Japanese Study Grp Pediat Liver Tumor, Tokyo, Japan
[7] Japanese Study Grp Pediat Liver Tumor, Saitama, Japan
[8] Japanese Study Grp Pediat Liver Tumor, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10021
引用
收藏
页数：1
相关论文
共 50 条
  • [11] A Single Center's Experience With Adherence to a Newly Implemented Risk-Stratified Immunosuppression Protocol in Renal Transplant Patients.
    Hurrell, M.
    Agarwal, A.
    Eymard, C.
    Keith, D.
    Brayman, K.
    Ally, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 583 - 583
  • [12] Effects of a Risk-Stratified Treatment in Patients with Chronic Back Pain in Rehabilitation: Results of a Controlled Clinical Trial
    Schmidt, Christian
    Bernert, Sebastian
    Sing, Matthias
    Fahrenkrog, Sandra
    Urbanski-Rini, Dominika
    Gottfried, Thomas
    Spyra, Karla
    PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN, 2021, 31 (01) : 34 - 42
  • [13] A Single Center's Experience With Adherence to a Newly Implemented Risk-Stratified Immunosuppression Protocol in Renal Transplant Patients.
    Hurrell, M.
    Agarwal, A.
    Eymard, C.
    Keith, D.
    Brayman, K.
    Ally, W.
    TRANSPLANTATION, 2014, 98 : 583 - 583
  • [14] 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
    Szuber, Natasha
    Mudireddy, Mythri
    Nicolosi, Maura
    Penna, Domenico
    Vallapureddy, Rangit R.
    Lasho, Terra L.
    Finke, Christy
    Begna, Kebede H.
    Elliott, Michelle A.
    Hook, C. Christopher
    Wolanskyj, Alexandra P.
    Patnaik, Mrinal M.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Sirhan, Shireen
    Pardanani, Animesh
    Gangat, Naseema
    Busque, Lambert
    Tefferi, Ayalew
    MAYO CLINIC PROCEEDINGS, 2019, 94 (04) : 599 - 610
  • [15] RISK-STRATIFIED SURVEILLANCE PROTOCOL IMPROVES COST-EFFECTIVENESS AFTER RADICAL NEPHROURETERECTOMY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA
    Masaki, Momota
    Shingo, Hatakeyama
    Yuki, Tobisawa
    Tohru, Yoneyama
    Hayato, Yamamoto
    Takahiro, Yoneyama
    Yasuhiro, Hashimoto
    Takuya, Koie
    Ikuya, Iwabuchi
    Masaru, Ogasawara
    Toshiaki, Kawaguchi
    Chikara, Ohyama
    JOURNAL OF UROLOGY, 2018, 199 (04): : E217 - E217
  • [16] Mitigation of postoperative urinary retention among total joint replacement patients using the ERAS protocol and applying risk-stratified catheterization
    Peng, Hui-ming
    Tong, Bing-du
    Li, Ye
    Wang, Wei
    Li, Wen-li
    Gao, Na
    ANZ JOURNAL OF SURGERY, 2022, 92 (09) : 2235 - 2241
  • [17] 3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups
    Szuber, Natasha
    Mudireddy, Mythri
    Nicolosi, Maura
    Penna, Domenico
    Vallapureddy, Rangit
    Lasho, Terra L.
    Finke, Christy
    Begna, Kebede H.
    Elliott, Michelle A.
    Hook, C. Christopher
    Wolanskyj, Alexandra
    Patnaik, Mrinal M.
    Hanson, Curtis A.
    Ketterling, Rhett P.
    Sirhan, Shireen
    Pardanani, Animesh
    Gangat, Naseema
    Busque, Lambert
    Tefferi, Ayalew
    BLOOD, 2018, 132
  • [18] Outcome of B-ALL Treated with A Risk-Stratified and Response-Adapted Protocol: Interim Analysis of A Single-Institution Pilot Study for A Multicenter Collaborative Protocol from India
    Narula, G.
    Arora, B.
    Subramanian, P.
    Tembhare, P.
    Patkar, N.
    Shetty, D.
    Prasad, M.
    Gujral, S.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S17 - S18
  • [19] Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective study
    Mahmoud, R.
    Savelkoul, E.
    Mares, W.
    Goetgebuer, R.
    Witteman, B.
    de Koning, D.
    Minderhoud, I.
    van Tuyl, S.
    van Boeckel, P.
    Mahmmod, N.
    Lutgens, M.
    Horjus, C.
    Romkens, T.
    Akol-Simsek, D.
    Jansen, J.
    Hoentjen, F.
    Jharap, B.
    Oldenburg, B.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I113 - I114
  • [20] Updated survival with extended follow-up on patients with newly diagnosed multiple myeloma treated with lenalidomide, bortezomib, and dexamethasone (RVD) induction therapy and a risk-stratified maintenance approach.
    Parikh, Rujul H.
    Hofmeister, Craig C.
    Almaula, Dhwani
    Heffner, Leonard T.
    Gupta, Vikas Anand
    Boise, Lawrence
    Kaufman, Jonathan L.
    Dhodapkar, Madhav V.
    Lonial, Sagar
    Nooka, Ajay K.
    Joseph, Nisha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345